Champions Oncology (CSBR)
Provides oncology research services, patient-derived models, testing platforms, and data offerings for biopharma.
$5.15
At close+0.15 (+3.00%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions25 holders · as of Mar 31, 2026 | 41.26% | 5.73M shares | |
| Insiders2 holders · as of Nov 6, 2025 | 7.65% | 1.06M shares | |
| Otherremainder | 51.09% | 7.10M shares |
13.89M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
25 holders · 5.73M shares · 4 new positions · 9 increased · 7 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Battery Management Corp. | 2.42M | 17.43% | 0 | May 15, 2026 |
| Nea Management Company, LLC | 1.71M | 12.33% | 0 | May 15, 2026 |
| Tocqueville Asset Management L.P. | 319.7K | 2.30% | 0 | May 12, 2026 |
| Vanguard Capital Management LLC | 299.5K | 2.16% | +299.5Knew | May 15, 2026 |
| Morgan Stanley | 242.3K | 1.74% | +12.6K | May 15, 2026 |
| Renaissance Technologies LLC | 145.5K | 1.05% | −9.3K | May 14, 2026 |
| BlackRock, Inc. | 123.9K | 0.89% | +1.1K | May 13, 2026 |
| Mink Brook Asset Management LLC | 111.3K | 0.80% | +31.0K | Apr 1, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.